Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice

• Published in: Vaccine Vol. 40; no. 31; pp. 4211 - 4219
• Main Authors: Zhao, Fu-jie, Liu, Lin-tao, Wang, Zi, Wang, Nian-xiang, Ma, Meng-yao, Jia, Xin-hao, Lu, Si-jia, Xiang, Yu-qiang, Zheng, Lan-lan, Hu, Hui
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 29.07.2022; Elsevier Limited
• Subjects: Adjuvants; Al(OH)3; Animal vaccines; Animals; Antibodies; Antigens; Chemokines; Coronaviruses; COVID-19; CXCL13 protein; Cytokines; Cytotoxicity; Deactivation; Deltacoronavirus; Diarrhea; Hogs; Immunization; Immunogenicity; Immunoglobulin G; Inactivated vaccine; Interleukin 4; Laboratory animals; Ligands; Lymphocytes; Lymphocytes T; Mice; ODN2395; PDCoV; Suckling behavior; Swine; Swine Diseases; Vaccines; Vaccines, Inactivated; Viruses; γ-Interferon; United States > US; China; PDCoV; IFN-γ; Immunogenicity; Inactivated vaccine; ODN; IL-4; Al(OH)3; CXCL13; ODN2395; Al(OH)
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2022.05.085

Porcine deltacoronavirus (PDCoV) is a novel coronavirus that causes diarrhea in pigs of various ages, especially in suckling piglets, and there are no effective measures to prevent and control PDCoV currently. In this study, two adjuvants Al(OH)3 and ODN2395 working through different mechanisms were used to prepare inactivated PDCoV vaccines, and the immune effects of PDCoV inactivated vaccines were assessed in mice. From the results, we found that both PDCoV/Al(OH)3 vaccine and PDCoV/2395 vaccine could induce IgG and neutralizing antibodies with high levels in mice. At the same time, cytokines of IFN-γ, IL-4 and chemokine ligand of CXCL13 in serum were significantly increased after immunization, and reached the highest levels in PDCoV/2395 vaccine group, which suggested that PDCoV/2395 could promote the production of both Th1 and Th2 polarized cytokines. In addition, histopathological observations showed that vaccination helped mice resist PDCoV infection. These results indicated that both the two inactivated vaccines have good immune effects. Moreover, the PDCoV/2395 vaccine worked better than the PDCoV/Al(OH)3 vaccine for PDCoV/2395 having the good ability to induce both humoral and cellular immunogenicity. The PDCoV/2395 inactivated vaccine developed in this study might be an effective tool for the prevention of PDCoV infection.